Q32 Bio Inc. (QTTB)

NCM – Real vaqt narxi. Valyuta: USD

15.43

+0.02 (0.13%)

Bozor ochiq: Aug 12, 2026, 1:12 PM EDT

15.41

0.00 (0.00%)

Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT

05.08.2026

Q32 Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update

-- Reported positive bempikibart 36-week topline results from Part B of SIGNAL-AA clinical trial; additional details from 36-week results and initial findings from 52-week results to be presented at a medical conference in the second half of 2026 -- -- Patient enrollment and dosing in SIGNAL-AA Part B open-label extension (OLE) ongoing -- -- Registration-directed program evaluating bempikibart in patients with severe or very severe AA expected to initiate in 1H'2027 subject to planned regulatory discussions later this year -- -- Half-life extended fully human anti-IL-7Rα antibody, ADX-914-XL, advancing in pre-clinical development -- -- Completed $200 million public offering in July 2026 -- -- Cash and cash equivalents of $106.3 million as of June 30, 2026, combined with proceeds from July 2026 public offering, are expected to provide financial runway through Phase 3 topline results from planned registration-directed program -- WALTHAM, Mass., Aug. 5, 2026 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata ("AA") and other autoimmune and inflammatory diseases, today reported financial results for the quarter ended June 30, 2026, and provided recent corporate updates.

Videolar

No Data

There is no data to display

Press-relizlar

05.08.2026

Q32 Bio Inc. (QTTB)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Q32 Bio Inc. (QTTB)

Q32 Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Videolar

No Data

Press-relizlar

Q32 Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Q32 Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Videolar

No Data

Press-relizlar

Q32 Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Search stocks

Q32 Bio Inc. (QTTB)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Q32 Bio Inc. (QTTB)

Q32 Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Videolar

No Data

Press-relizlar

Q32 Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Q32 Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Videolar

No Data

Press-relizlar

Q32 Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update